Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECP vs Corticosteroids in SPMS
NCT02296346Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Oct 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in secondary-progressive multiple sclerosis (SPMS), sponsored by University of Utah. Started Oct 2014; status: terminated.
02
Drugs
methoxsalen
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT02296346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02296346.